Insider Ownership
CEOAHMED NADIM
President and CEO
OtherSavill Corrine
Chief Business Officer
OtherJones Jeffrey Alan
Chief Medical Officer
OtherSUMER JACQUELYN L
Chief Legal Officer
OtherMichaelson Jennifer
Chief Scientific Officer
CFOFenton Mary Kay
Chief Financial Officer
Transactions
50 transactions · page 3
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|
| 2022-05-12 | BVF PARTNERS L P/IL | 10% Owner | Buy | 1,000,000 | $9.06 | $9,060,000.00 | +19.0% | → |
| 2022-05-12 | F2 Vision SCS | - | Sell | 264,072 | $9.25 | $2,442,586.78 | -15.3% | → |
| 2022-04-01 | BVF PARTNERS L P/IL | 10% Owner | Buy | 276,000 | $10.75 | $2,966,972.40 | +5.5% | → |
| 2021-10-18 | Michaelson Jennifer | See Remarks | Sale+OE | 4,000 | $21.42 | $85,669.20 | -5.4% | → |
| 2021-10-15 | Trigilio Jeffrey | Chief Financial Officer | Sale+OE | 8,000 | $25.00 | $200,000.00 | -78.0% | → |
| 2021-10-15 | Zawel Leigh | See Remarks | Sell | 19,574 | $25.00 | $489,350.00 | -34.4% | → |
| 2021-10-07 | Zawel Leigh | See Remarks | Sell | 1,079 | $25.00 | $26,975.00 | -1.9% | → |
| 2021-09-20 | Michaelson Jennifer | See Remarks | Sale+OE | 4,000 | $24.51 | $98,048.00 | -7.9% | → |
| 2021-09-20 | Zawel Leigh | See Remarks | Sell | 7,468 | $25.16 | $187,894.88 | -11.4% | → |
| 2021-09-16 | GADICKE ANSBERT | Director, 10% Owner | Sell | 3,556 | $29.06 | $103,337.36 | - | → |
| 2021-09-16 | UBS Oncology Impact Fund L.P. | 10% Owner | Sell | 3,124 | $29.06 | $90,783.44 | - | → |
| 2021-09-15 | GADICKE ANSBERT | Director, 10% Owner | Sell | 15,401 | $29.17 | $449,174.04 | - | → |
| 2021-09-15 | UBS Oncology Impact Fund L.P. | 10% Owner | Sell | 13,531 | $29.17 | $394,635.02 | - | → |
| 2021-09-13 | UBS Oncology Impact Fund L.P. | 10% Owner | Sell | 23,253 | $29.23 | $679,738.19 | -0.1% | → |
| 2021-09-13 | GADICKE ANSBERT | Director, 10% Owner | Sell | 26,468 | $29.23 | $773,719.99 | -0.1% | → |
| 2021-09-08 | Trigilio Jeffrey | Chief Financial Officer | Sale+OE | 15,000 | $28.48 | $427,153.26 | -51.7% | → |
| 2021-09-08 | Baeuerle Patrick | See Remarks | Sale+OE | 11,000 | $28.45 | $312,950.00 | -100% | → |
| 2021-09-08 | UBS Oncology Impact Fund L.P. | 10% Owner | Sell | 48,640 | $29.20 | $1,420,393.90 | -0.2% | → |
| 2021-09-08 | GADICKE ANSBERT | Director, 10% Owner | Sell | 55,364 | $29.20 | $1,616,749.39 | -0.2% | → |
| 2021-09-07 | Zawel Leigh | See Remarks | Sell | 28,118 | $28.95 | $814,016.10 | -30.1% | → |
| 2021-09-02 | GADICKE ANSBERT | Director, 10% Owner | Sell | 23,649 | $29.46 | $696,756.68 | -0.1% | → |
| 2021-09-02 | UBS Oncology Impact Fund L.P. | 10% Owner | Sell | 21,471 | $29.46 | $632,592.80 | -0.1% | → |